Poongjeon Pharmacy CO.,LTD.
Research Poongjeon Pharmacy CO.,LTD. (298060.KQ) on Bullrun: market cap KRW 21.15B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker298060.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 21.15B
- Financial periodQ2 2026
- RevenueKRW 11.99B
- Net income-KRW 3.94B
- Gross margin26.0%
Valuation Snapshot
latest market cap is KRW 21.15B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 21.15B | n/a | n/a | n/a |
Dividend history
About Poongjeon Pharmacy CO.,LTD.
POONGJEON PHARMACY CO.,LTD. operates as a stem cell therapy company in South Korea. It develops SCM-AGH, a treatment for moderate to severe acute pancreatitis and moderate to severe atopic dermatitis, as well as chronic graft versus host disease; and Iroro Deerscalp, a toothbrush cosmetic for hair loss relief. The company was formerly known as SCM Lifescience Co., Ltd. and change its name to POONGJEON PHARMACY CO.,LTD. in April 2026. The company was incorporated in 2014 and is headquartered in Incheon, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Poongjeon Pharmacy CO.,LTD.'s market cap?
Poongjeon Pharmacy CO.,LTD.'s market capitalization is KRW 21.15B.
What does Poongjeon Pharmacy CO.,LTD. do?
POONGJEON PHARMACY CO.,LTD. operates as a stem cell therapy company in South Korea. It develops SCM-AGH, a treatment for moderate to severe acute pancreatitis and moderate to severe atopic dermatitis, as well as chronic graft versus host disease; and Iroro Deerscalp, a toothbrush cosmetic for hair loss relief. The company was formerly known as SCM Lifescience Co., Ltd. and change its name to POONGJEON PHARMACY CO.,LTD. in April 2026. The company was incorporated in 2014 and is headquartered in Incheon, South Korea.